The on-site technical exchange meeting between Shandong Yinfeng Life Science Research Institute and Shandong University Qilu Hospital Orthopedics Department was successfully held
Release time:
2022-03-11
On the afternoon of March 8th, Jia Chunsheng, Vice President of Shandong Yinfeng Life Science Research Institute (our foundation's research unit), Liu Zhicheng, General Manager of Yinfeng Health Technology Service Co., Ltd., and Zang Chuanbao, Director of Cryogenic Medicine Research Center, were invited to participate in a hospital enterprise cooperation intention exchange meeting organized by the Orthopedics Department of Qilu Hospital, Shandong University. Liu Xinyu, Executive Deputy Director of Orthopedics and Director of Spinal Surgery at Qilu Hospital of Shandong University, Zhu Lei, Deputy Director of Orthopedics and Director of Hand and Foot Surgery, Cheng Lei, Deputy Director of Spinal Surgery, Xu Qingjia, Deputy Director of Hand and Foot Surgery, and more than 30 professional doctors and technical experts from the orthopedics department participated in this meeting.
At the meeting, the attending experts listened to the research progress of our hospital in the development of tissue engineering materials and medical devices, and discussed our cooperation intentions in the orthopedic application direction of our research products. They had in-depth exchanges on joint cartilage repair, spinal fusion repair, and other directions. Our collaborating expert, Professor Sun Wenquan from Shanghai University of Technology, specially attended this exchange meeting.
The R&D team of Yinfeng Low Temperature Medical Research Center has developed multiple forms of engineering materials using donated and clinically abandoned tissues of the same type, which have broad application prospects in filling and repairing various tissue defects. The orthopedic expert team of Qilu Hospital has shown strong interest in our hospital's related research and has reached an intention to further clinical cooperation.
According to incomplete statistics, there are currently 5-6 million patients with bone defects in China each year. However, the actual number of orthopedic surgeries using bone defect repair materials for treatment in China is only about 1.33 million per year. There is a strong demand for bone defect repair materials in clinical practice, and there is a huge gap in clinical demand that needs to be filled. We look forward to the rapid transformation and application of our research products in clinical practice, providing higher quality technical products and services for orthopedic patients.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
